Mortality in US Veterans with rheumatoid arthritis treated with immune checkpoint inhibitors

Abstract: Objective: This investigation compared all-cause and cause-specific mortality in patients with and without rheumatoid arthritis (RA) in the Veterans Health Administration …

Treatment duration of immune checkpoint inhibitors and overall survival in U.S. Veterans with cancer

Abstract: Background: Optimal treatment duration for immune checkpoint inhibitors (ICI) remains a clinical debate. The objective of this study was to contrast mortality rates …

Incidence of immune-related adverse events in US Veterans treated with immune checkpoint inhibitors

Abstract: Background: Immune checkpoint inhibitors (ICIs) are associated with potentially severe immune-related adverse events (irAEs). Emerging clinical practice reports have …

Real-world effectiveness of immune checkpoint inhibitors and BRAF/MEK inhibitors among Veteran patients with cutaneous melanoma

Abstract: The Veterans Health Administration is the largest integrated health care system in the United States, caring for more than 9 million individuals. Despite higher cutaneous …